1. Computational and Systems Biology
  2. Immunology and Inflammation
Download icon

Computer-guided design of optimal microbial consortia for immune system modulation

  1. Richard R Stein  Is a corresponding author
  2. Takeshi Tanoue
  3. Rose L Szabady
  4. Shakti K Bhattarai
  5. Bernat Olle
  6. Jason M Norman
  7. Wataru Suda
  8. Kenshiro Oshima
  9. Masahira Hattori
  10. Georg K Gerber
  11. Chris Sander
  12. Kenya Honda
  13. Vanni Bucci  Is a corresponding author
  1. Dana-Farber Cancer Institute, United States
  2. RIKEN Institute, Japan
  3. Vedanta Biosciences, Inc, United States
  4. University of Massachusetts, United States
  5. Keio University School of Medicine, Japan
  6. The University of Tokyo, Japan
  7. Brigham and Women's Hospital, United States
Research Article
  • Cited 17
  • Views 5,993
  • Annotations
Cite this article as: eLife 2018;7:e30916 doi: 10.7554/eLife.30916

Abstract

Manipulation of the gut microbiota holds great promise for the treatment of diseases. However, a major challenge is the identification of therapeutically potent microbial consortia that colonize the host effectively while maximizing immunologic outcome. Here, we propose a novel workflow to select optimal immune-inducing consortia from microbiome composition and immune effectors measurements. Using published and newly generated microbial and regulatory T-cell (Treg) data from germ-free mice, we estimate the contribution of twelve Clostridia strains with known immune-modulating effect to Treg induction. Combining this with a longitudinal data-constrained ecological model, we predict the ability of every attainable and ecologically stable subconsortium in promoting Treg activation and rank them by the Treg Induction Score (TrIS). Experimental validation of selected consortia indicates a strong and statistically significant correlation between predicted TrIS and measured Treg. We argue that computational indexes, such as the TrIS, are valuable tools for the systematic selection of immune-modulating bacteriotherapeutics.

Article and author information

Author details

  1. Richard R Stein

    Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, United States
    For correspondence
    stein@jimmy.harvard.edu
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5110-6863

  2. Takeshi Tanoue

    Center for Integrative Medical Sciences, RIKEN Institute, Yokohama City, Japan
    Competing interests
    Takeshi Tanoue, Has received support from Vedanta Biosciences, Inc. under research agreement with his institution.

  3. Rose L Szabady

    Vedanta Biosciences, Inc, Cambridge, United States
    Competing interests
    Rose L Szabady, Is employee of Vedanta Biosciences, Inc.

  4. Shakti K Bhattarai

    Engineering and Applied Sciences PhD Program, University of Massachusetts, Dartmouth, United States
    Competing interests
    No competing interests declared.

  5. Bernat Olle

    Vedanta Biosciences, Inc, Cambridge, United States
    Competing interests
    Bernat Olle, Is the Chief Executive Officer of Vedanta Biosciences, Inc.

  6. Jason M Norman

    Vedanta Biosciences, Inc, Cambridge, United States
    Competing interests
    Jason M Norman, Is employee of Vedanta Biosciences, Inc.

  7. Wataru Suda

    Department of Microbiology and Immunology, Keio University School of Medicine, Tokyo, Japan
    Competing interests
    No competing interests declared.

  8. Kenshiro Oshima

    Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan
    Competing interests
    No competing interests declared.

  9. Masahira Hattori

    Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan
    Competing interests
    No competing interests declared.

  10. Georg K Gerber

    Massachusetts Host-Microbiome Center, Department of Pathology, Brigham and Women's Hospital, Boston, United States
    Competing interests
    Georg K Gerber, Is a member of the Scientific Advisory Board of Kaleido, Inc.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9149-5509

  11. Chris Sander

    Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, United States
    Competing interests
    No competing interests declared.

  12. Kenya Honda

    Center for Integrative Medical Sciences, RIKEN Institute, Yokohama City, Japan
    Competing interests
    Kenya Honda, Is a Co-Founder and Scientific Advisory Board Member of Vedanta Biosciences, Inc. Has received support from Vedanta Biosciences, Inc. under research agreements with his institution.

  13. Vanni Bucci

    Engineering and Applied Sciences PhD Program, University of Massachusetts, Dartmouth, United States
    For correspondence
    vanni.bucci@umassd.edu
    Competing interests
    Vanni Bucci, Has received support from Vedanta Biosciences, Inc. under research agreement with his institution.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3257-2922

Funding

National Institutes of Health (P41 GM103504)

  • Richard R Stein
  • Chris Sander

Brigham and Women's Hospital (Precision Medicine Initiative)

  • Georg K Gerber

Defense Advanced Research Projects Agency (BRICS award HR0011-15-C-0094)

  • Georg K Gerber

Human Frontier Science Program (RGP00055/2015)

  • Chris Sander

Takeda Science Foundation

  • Kenya Honda

National Institute of General Medical Sciences (5R01 GM106303)

  • Chris Sander

Japan Agency for Medical Research and Development

  • Kenya Honda

National Institute of Allergy and Infectious Diseases

  • Vanni Bucci

National Science Foundation

  • Vanni Bucci

Core Research for Evolutional Science and Technology

  • Kenya Honda

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: 11-strain time-series mouse experiments were performed under ethical approval by RIKEN, Keio and Azabu Universities under protocol H24-9(14) (RIKEN). 4-strain validation mouse work was performed at Brigham and Women's Hospital in Boston, MA in the Massachusetts Host Microbiome Center under IACUC protocol 2016N000141.

Reviewing Editor

  1. Rob Knight, University of California, San Diego, United States

Publication history

  1. Received: August 1, 2017
  2. Accepted: March 31, 2018
  3. Accepted Manuscript published: April 17, 2018 (version 1)
  4. Version of Record published: May 11, 2018 (version 2)

Copyright

© 2018, Stein et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 5,993
    Page views
  • 1,061
    Downloads
  • 17
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, Scopus, PubMed Central.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Download citations (links to download the citations from this article in formats compatible with various reference manager tools)

Open citations (links to open the citations from this article in various online reference manager services)

Categories and tags

Research organisms

Further reading

    1. Microbiology and Infectious Disease

    Mechanistic Microbiome Studies: A Special Issue

    Edited by Wendy S Garrett et al.
    Collection

    eLife is pleased to present a Special Issue to highlight recent advances in the mechanistic understanding of microbiome function.

    1. Computational and Systems Biology
    2. Evolutionary Biology

    Repeated outbreaks drive the evolution of bacteriophage communication

    Hilje M Doekes et al.
    Research Article Updated

    Recently, a small-molecule communication mechanism was discovered in a range of Bacillus-infecting bacteriophages, which these temperate phages use to inform their lysis-lysogeny decision. We present a mathematical model of the ecological and evolutionary dynamics of such viral communication and show that a communication strategy in which phages use the lytic cycle early in an outbreak (when susceptible host cells are abundant) but switch to the lysogenic cycle later (when susceptible cells become scarce) is favoured over a bet-hedging strategy in which cells are lysogenised with constant probability. However, such phage communication can evolve only if phage-bacteria populations are regularly perturbed away from their equilibrium state, so that acute outbreaks of phage infections in pools of susceptible cells continue to occur. Our model then predicts the selection of phages that switch infection strategy when half of the available susceptible cells have been infected.

    1. Chromosomes and Gene Expression
    2. Computational and Systems Biology

    Effective dynamics of nucleosome configurations at the yeast PHO5 promoter

    Michael Roland Wolff et al.
    Research Article

    Chromatin dynamics are mediated by remodeling enzymes and play crucial roles in gene regulation, as established in a paradigmatic model, the S. cerevisiae PHO5 promoter. However, effective nucleosome dynamics, i.e. trajectories of promoter nucleosome configurations, remain elusive. Here, we infer such dynamics from the integration of published single-molecule data capturing multi-nucleosome configurations for repressed to fully active PHO5 promoter states with other existing histone turnover and new chromatin accessibility data. We devised and systematically investigated a new class of 'regulated on-off-slide' models simulating global and local nucleosome (dis)assembly and sliding. Only seven of 68145 models agreed well with all data. All seven models involve sliding and the known central role of the N-2 nucleosome, but regulate promoter state transitions by modulating just one assembly rather than disassembly process. This is consistent with but challenges common interpretations of previous observations at the PHO5 promoter and suggests chromatin opening by binding competition.